• Healthcare Investments and Exits Report 2018

    Healthcare Investments and Fundraising Reach All-Time Highs

    In our annual Healthcare Investments and Exits report, SVB analyzed the fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies.

    Investment and fundraising in the healthcare ecosystem set records in 2017, underscoring the strengths of biopharma Series A, new venture interest in medical devices and the promise of technology to advance Dx/Tools.

    The report highlights include:

    • U.S. healthcare venture fundraising reached $9.1 billion – a 26 percent increase over 2016 – and surpassed the 2015 record of $7.5 billion.
    • Investments into venture-backed biopharma, medical device and Dx/Tools companies also are expected to break records in 2017, increasing 31 percent over 2016 to reach $15.5 billion.
    • The biopharma IPO window continued to stay open, and saw record company pre-money valuations, though M&A exits declined.

  • Now let's get started

    See how Silicon Valley Bank makes next happen now for entrepreneurs like you.

    Connect With Us

Log in to